Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about European projects that are funded by European programmes including FP7, H2020, IMI, JNPD, AAL and EU Health. For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

blood Proteins for early Discrimination of dEmentias

bPRIDE

Dementia is a group of disorders characterized by severe memory loss ultimately impairing daily life activities. Major forms are Alzheimer’s disease, Lewy body dementia, and frontotemporal dementia. Each dementia type is caused by different biological factors and therefore requires a specific treatment targeting these factors. To develop effective...

Funding Programme
Start Date
End Date
Total Funding
€ 1 800 000
European Countries Involved

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

DISTINCT

The main aim of DISTINCT will develop a premier quality multi-disciplinary, multi-professional and intersectorial education and training research framework for Europe aimed at improving technology and care for people with dementia and their carers, and to use coherent themes an.d interrelated ESRs within DISTINCT to provide the evidence to show how...

Funding Programme
Start Date
End Date
Total Funding
€ 3 998 048
European Countries Involved

Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders

NEUROFGL

Neurodegenerative disorders such as, Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), stroke, Traumatic Brain Injury (TBI) and chronic stress create a major economic burden to society and a substantial reduction in quality of life for patients and families. The development of neuroregenerative therapies is notoriously difficult and...

Funding Programme
Start Date
End Date
Total Funding
€ 7 807 910
European Countries Involved

From air pollution to brain pollution – novel biomarkers to unravel the link of air pollution and Alzheimer’s disease

ADAIR

Alzheimer’s disease (AD) is a devastating disorder without a cure. Recent research demonstrates a link between AD and exposure to high levels of air pollution, yet detailed understanding of the connection does not exist. Air pollution, a massive public health issue known to pose a major threat to humans, is an increasing global concern. Researchers...

Funding Programme
Start Date
End Date
Total Funding
€ 1 400 000
European Countries Involved

Identifying and treating SORL1-associated Alzheimer’s disease

SORLA-FIX

The majority of the risk to develop Alzheimer's disease is influenced by genetic factors. We previously found that carrying a genetic mutation in the SORL1 gene can lead to a greatly increased chance of developing Alzheimer's Disease. SORL1 is involved in the production and processing of Alzheimer proteins that accumulate in the brain. e have...

Funding Programme
Start Date
End Date
European Countries Involved

implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC

ADOPT BBMRI-ERIC

BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium, aims to establish, operate and develop a Pan-European distributed research infrastructure in order to facilitate the access to biological resources as well as facilities and to support high quality biomolecular and biomedical...

Funding Programme
Start Date
End Date
Total Funding
€ 4 949 449

Interdisciplinary Network for Dementia Utilising Current Technology (INDUCT)

INDUCT

Dementia raises complex challenges for people with dementia, their families, and society. The European Parliament has called for investment in high quality, innovative technology research to improve dementia care but so far there has been little benefit because research has generally been limited, small scale and methodologically flawed. In...

Funding Programme
Start Date
End Date
Total Funding
€ 3 878 757
European Countries Involved

Large scale interactions in brain networks and their breakdown in brain diseases

BRAINSYNC

The long-term goal of this project is to understand how neuronal assemblies exchange information (functional or neuronal communication), and how variability in neuronal communication explains variability in behavioural performance, both in the intact and injured brain. Communication involves temporal interactions between neuronal assemblies either...

Funding Programme
Start Date
End Date
Total Funding
€ 3 933 811
European Countries Involved

Magnetic DIagnostic Assay for neurodegenerative diseases

MADIA

MADIA aims at realizing a versatile and cheap diagnostic device based on magnetoresistive sensors, microfluidic device, ultra–small Magnetic Nanoparticles (MNPs) and advanced bio-chemical functionalization methods for the early and ultrasensitive. in vitro detection of biomarkers trustfully associated with 2 incurable neurodegenerative diseases...

Funding Programme
Start Date
End Date
Total Funding
€ 3 891 062
European Countries Involved

Nanosystems for the early Diagnosis of Neurodegenerative diseases

NADINE

Medical diagnosis is currently undergoing a major revolution due to the fast discovery of molecular biomarkers, and the development of multimodal “metabiomarker” signatures. Progress, however, is hindered by low abundance of many biomarkers of interest in body fluids, in absolute concentration and with regard to other biomolecules. The aim of the...

Funding Programme
Start Date
End Date
Total Funding
€ 11 702 928
European Countries Involved

Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems

Bio2Brain

Bio2Brain aims to create a trans-European network of industrially oriented specialists fully trained and experienced, a significant driving force in innovating novel technologies to deliver biopharmaceuticals safely and via the nasal route of administration to the central nervous system (CNS). Diseases of the CNS and the spinal cord affect around...

Funding Programme
Start Date
End Date
Total Funding
€ 3 497 298
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).